Nephrectomy: Clinical Trials

2 trials of Nephrectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Terminated 1

Follow Nephrectomy: new trials by email Literature Review of Nephrectomy trials Research Report on Nephrectomy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
Biopsy, Daratumumab, Laboratory Biomarker Analysis - Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma
Early Phase 1CompletedM.D. Anderson Cancer Center172018-05-292025-01-30
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
Enzalutamide, Laboratory Biomarker Analysis, Nephrectomy - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer
Early Phase 1TerminatedRutgers, The State University of New Jersey32017-12-052021-09-16

Conditions studied

Carcinoma, Renal Cell (2)  ·  Urologic Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (2)

Top investigators

Eric Singer (1)  ·  Matthew T Campbell (1)

NIH funding

P30CA016672 (1), P30CA072720 (1)